Found 12 matching trials
Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue PHASE3 The purpose of this study is to investigate lot-to-lot consistency in terms...
Show More Learn More & Join Trial
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers PHASE3 Dengue fever is caused by an infection with the dengue virus. Vaccination w...
Show More Location
Clinica de la Costa Ltda
Learn More & Join Trial
A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan PHASE2 Dengue fever is caused by an infection with the dengue virus. Vaccination w...
Show More Learn More & Join Trial
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults PHASE3 The main purpose of this study is to assess the immunogenicity and safety o...
Show More Location
Coastal Clinical Research Inc
Learn More & Join Trial
Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years PHASE3 The purpose of the study is to demonstrate the non-inferiority (NI) of the ...
Show More Learn More & Join Trial
Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination N/A The goal of this observational study is to learn about the immunity induced...
Show More Location
IRCCS Sacro Cuore Don Calabria
Learn More & Join Trial
A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults PHASE3 Dengue fever is caused by an infection with the dengue virus. Vaccination w...
Show More Status
Active Not Recruiting
Location
Paratus Clinical Research Western Sydney
Learn More & Join Trial
Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina. N/A The TAK-003 vaccine, Qdenga, developed by Takeda, was approved by ANMAT in ...
Show More Status
Active Not Recruiting
Location
Fundación Vacunar
Learn More & Join Trial
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) PHASE3 Dengue fever is caused by an infection with the dengue virus. Vaccination w...
Show More Location
Fundacion Huesped - PPDS
Learn More & Join Trial
Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam N/A The study aims to retrospectively describe the demographic characteristics,...
Show More Status
Active Not Recruiting
Location
Vietnam Vaccine Joint Stock Company
Learn More & Join Trial